← Back to Search

PrEP Master Adherence Intervention for HIV Prevention

N/A
Waitlist Available
Led By Jessy G Dévieux, Ph.D.
Research Sponsored by Florida International University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial will test an intervention program to improve HIV PrEP utilization among women of color who are at substantial risk for HIV, including alcohol use.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants receiving 3 Medication Appointments
Number of Participants reporting Adherence to HIV testing recommendation
Percentage Adherence to PrEP Medication
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: PrEP Master Adherence InterventionExperimental Treatment1 Intervention
The intervention consists of an introductory session and 4 individual sessions led by the PrEP Master, over an 8 week period. Between the sessions, the PrEP Master will conduct weekly check-in calls to participants to encourage adherence and assist with difficulties. During the weekly check-in, side effects and their impact will be assessed using assessment measures.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PrEP Master Adherence Intervention
2019
N/A
~40

Find a Location

Who is running the clinical trial?

Florida International UniversityLead Sponsor
100 Previous Clinical Trials
17,517 Total Patients Enrolled
Jessy G Dévieux, Ph.D.Principal InvestigatorFlorida International Univ.
~6 spots leftby Jun 2025